Pilot Study to Establish Safety & Efficacy of a Combination of Dexamethasone and Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL)
Conditions
- Chronic Lymphocytic Leukemia
Interventions
- DRUG: Lenalidomide & Dexamethasone
Sponsor
University College, London